Chengli Du
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
Papers in
-
- Ubiquitin and proteasome pathways 2
- Heat shock proteins research 2
- Cancer-related gene regulation 2
- RNA Research and Splicing 2
- Histone Deacetylase Inhibitors Research 2
-
- Lung Cancer Diagnosis and Treatment 5
- Co-authors
- Haiyang Xie (15 shared papers)Jian Wu (13 shared papers)Shusen Zheng (14 shared papers)Zhen Lv (12 shared papers)Chaofeng Ding (12 shared papers)Heng Xiao (8 shared papers)Shaobing Cheng (8 shared papers)Lin Zhou (6 shared papers)
- Journals
- Cancer Letters (3 papers)Annals of Translational Medicine (3 papers)International Journal of Molecular Sciences (2 papers)Oncotarget (2 papers)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaMadagascarSpain
In The Last Decade
Chengli Du
32 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 76
- Cancer Research 438
- Molecular Biology 614
- Oncology 186
- Immunology 62
- Pulmonary and Respiratory Medicine 87
Countries citing papers authored by Chengli Du
This map shows the geographic impact of Chengli Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengli Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengli Du more than expected).
Fields of papers citing papers by Chengli Du
This network shows the impact of papers produced by Chengli Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengli Du. The network helps show where Chengli Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Chengli Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 140 | |
| 2 | 2014 | 113 | |
| 3 | 2019 | 105 | |
| 4 | 2014 | 101 | |
| 5 | 2013 | 87 | |
| 6 | 2015 | 62 | |
| 7 | 2015 | 46 | |
| 8 | 2021 | 43 | |
| 9 | 2014 | 42 | |
| 10 | 2013 | 41 | |
| 11 | 2015 | 39 | |
| 12 | 2014 | 34 | |
| 13 | 2016 | 28 | |
| 14 | 2016 | 24 | |
| 15 | 2019 | 20 | |
| 16 | 2014 | 18 | |
| 17 | 2017 | 17 | |
| 18 | 2020 | 15 | |
| 19 | 2021 | 13 | |
| 20 | 2020 | 9 |
About Chengli Du
Chengli Du is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Cell Biology, having authored 32 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (5 papers), Ubiquitin and proteasome pathways (2 papers), Heat shock proteins research (2 papers), Cancer-related Molecular Pathways (2 papers), Cancer-related gene regulation (2 papers), RNA Research and Splicing (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Cancer Research (438 citations), Molecular Biology (614 citations), Oncology (186 citations), Immunology (62 citations) and Pulmonary and Respiratory Medicine (87 citations). Chengli Du has collaborated with scholars based in China, Madagascar and Spain. Frequent co-authors include Haiyang Xie, Jian Wu, Shusen Zheng, Zhen Lv, Chaofeng Ding, Heng Xiao, Shaobing Cheng, Lin Zhou, Chuanhui Peng and Lin Zhou. Their work appears in journals such as Cancer Letters, Annals of Translational Medicine, International Journal of Molecular Sciences, Oncotarget and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.